• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Medicamen Biotech Limited — Board Meeting, 13-02-2026: Outcome of Board Meeting

    13-02-2026 | 04:01 pm

    Medicamen Biotech's board approved Q3 & nine-month financial results ending Dec 31, 2025. Consolidated comprehensive income for Q3 was 163.47, with EPS at 1.21 Rs. The company also announced the cessation of two Independent Directors, leading to committee reconstitutions.

    No comments yet. Be the first to comment!

    All announcements from Medicamen Biotech Limited